USP advisory panel on the USP performance test for topical and transdermal dosage forms

Pharmacopeial Forum

Volumn 32, Issue 5, 2006, Pages

  Shah, Vinod P ^a   Ueda, Clarence T ^a  

^a USP Advisory Panel on Topical and Transdermal Dosage Forms Testing ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34848833291     PISSN: 03634655     EISSN: 15421945     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. International Conference on Harmonization. Q6A. Specifications: test procedures and acceptance criteria for new drug substances and new drug products chemical substances. 1999. Available at: www.ich.org/LOB/media/MEDIA430.pdf. Accessed April 25, 2006.
2. Marshall K, Foster TS, Carlin HS, Williams RL. Development of a compendial taxonomy and glossary for pharmaceutical dosage forms. Pharm Forum . 2003;29:1742-1752.
3. Shargel L, Foster T. USP advisory panels on the USP performance test. Pharm Forum. 2005;31(6):1742-1744. (Pubitemid 44147288)
4. Flynn GL, Shah VP, Tenjarla SN, et al. Assessment of value and applications of in vitro testing of topical dermatological drug products [Workshop Report]. Pharm Res. 1999;16(9):1325-1330. (Pubitemid 29449367)
5. Van Buskirk GA, González MA, Shah VP, et al. Scale-up of adhesive transdermal drug delivery systems [Workshop Report]. Pharm Res. 1997;14 (7):848-852.
6. Siewert M, Dressman J, Brown CK, et al. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech [serial online]. 2003;4(1):article 7. Available at: www.aapspharmscitech.org/articles/pt0401/pt040107/pt040107.pdf. Accessed April 25, 2006.